Dr. Aude Segaliny, PhDSenior Director, Head of Research & Early Development at Amberstone BiosciencesSpeaker
Profile
Dr. Aude Segaliny, founding scientist and Vice President of Research & Development at Amberstone Biosciences, pioneers next-generation therapeutics with enhanced precision and a markedly improved therapeutic window. Her work is dedicated to advancing safer, more potent treatment options for patients that surpass current standards of care.
Agenda Sessions
Redefining TCEs for Solid Tumors: Precision Safety, Efficacy Unlocked
, 14:45View Session
